Summary of Classification and Labelling
Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)
General Information
Index Number EC / List no. CAS Number International Chemical Identification
017-006-00-4 231-512-4 7601-90-3 perchloric acid ... %

ATP Inserted / Updated: CLP00
CLP Classification (Table 3)
Classification Labelling Specific Concentration limits, M-Factors, Acute Toxicity Estimates (ATE) Notes
Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Eye Irrit. 2; H319: 1 % ≤ C < 10 %
Ox. Liq. 1; H271: C > 50 %
Ox. Liq. 2; H272: C ≤ 50 %
Skin Corr. 1A; H314: C ≥ 50 %
Skin Corr. 1B; H314: 10 % ≤ C < 50 %
Skin Irrit. 2; H315: 1 % ≤ C < 10 %
Note B
Skin Corr. 1A H314 H314

Signal Words Pictograms
Danger
GHS03
Flame over circle
GHS05
Corrosion
Seveso III Data
Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.

Seveso Data
Seveso Substance Seveso Categories
Ja P8
Notified classification and labelling
General Information
EC / List no.
Name CAS Number
231-512-4 Perchloric acid 7601-90-3

Notified classification and labelling according to CLP criteria
Classification Labelling Specific Concentration limits, M-Factors Notes Classification affected by Impurities / Additives

Additional Notified Information

Number of Notifiers

Joint Entries

Hazard Class and Category Code(s) Hazard Statement Code(s) Hazard Statement Code(s) Supplementary Hazard Statement Code(s) Pictograms, Signal Word Code(s)
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Ox. Liq. 2; : C ≤ 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1A; : C ≥ 50 %
Ox. Liq. 1; : C > 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
State/Form
13 yes View details
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS08
GHS07
GHS05
Dgr
Skin Corr. 1A; : C ≥ 50 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Ox. Liq. 2; : C ≤ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Ox. Liq. 1; : C > 50 %
State/Form
12 yes View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
STOT RE 2 H373 (Thyroid) H373 (Thyroid)
STOT RE 2 H373 (other:Thyroid) H373 (Thyroid)
Ox. Liq. 1 H271 H271 GHS03
GHS07
GHS08
GHS05
Dgr
State/Form
1 yes View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
STOT RE 2 H373 (other:Thyroid) H373
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Ox. Liq. 1; : C > 50 %
Ox. Liq. 2; : C ≤ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Note B
State/Form
136 View details
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS07
GHS05
Dgr
Ox. Liq. 1; : C > 50 %
Skin Corr. 1A; : C ≥ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Ox. Liq. 2; : C ≤ 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Note B
State/Form
14 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS07
GHS08
GHS05
Dgr
6 View details
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318 H318
STOT SE 1 H370 (Respiratory tra...) (inhalation) H370 (i)
STOT SE 1 H370 (other:Respirato...) (inhalation) H370 (i)
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Skin Corr. 1B; : C ≥ 10 %
Skin Irrit. 2; : C ≥ 1 %
Ox. Liq. 1; : C ≥ 50.0001 %
Eye Irrit. 2; : C ≥ 1 %
Ox. Liq. 2; : C ≥ 50 %
Skin Corr. 1A; : C ≥ 50 %
Note B
State/Form
2 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
State/Form
1 View details
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Skin Corr. 1B; : 10 % ≤ C < 50 %
Ox. Liq. 1; : C > 50 %
Skin Corr. 1A; : C ≥ 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Ox. Liq. 2; : C ≤ 50 %
Note B
State/Form
1 View details
  H290
Skin Corr. 1A H314 H314
  H221 GHS03
GHS05
Dgr
State/Form
1 View details
Ox. Liq. 1 H271  
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Ox. Liq. 2; : C ≤ 50 %
Eye Irrit. 2; : 1 % ≤ C ≤ 10 %
Skin Irrit. 2; : 1 % ≤ C ≤ 10 %
Skin Corr. 1B; : 10 % ≤ C ≤ 50 %
Ox. Liq. 1; : C > 50 %
Skin Corr. 1A; : C > 50 %
Note B
State/Form
1 View details
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Skin Corr. 1B; : 10 % ≤ C < 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1A; : C ≥ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Ox. Liq. 2; : C ≤ 50 %
Ox. Liq. 1; : C > 50 %
Note B
State/Form
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Ox. Liq. 1; : C > 50 %
Skin Corr. 1A; : C ≥ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Ox. Liq. 2; : C ≤ 50 %
State/Form
1 View details
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS08
GHS05
Dgr
Skin Corr. 1A; : C ≥ 50 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Ox. Liq. 1; : C > 50 %
Ox. Liq. 2; : C ≤ 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
1 View details
Skin Corr. 1A H314 H314
STOT RE 2 H373 (Thyroids) (oral) H373
Ox. Liq. 1 H271 H271 GHS03
GHS08
GHS07
GHS05
Dgr
Ox. Liq. 1; : C > 50 %
Ox. Liq. 2; : C ≤ 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Note B
State/Form
1 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
STOT RE 2 H373 (other:thyroid) (dermal,inhalati...) H373
Ox. Liq. 1 H271 H271 GHS03
GHS08
GHS07
GHS05
Dgr
Ox. Liq. 1; : C > 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Ox. Liq. 2; : C ≤ 50 %
Skin Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1A; : C ≥ 50 %
Note B
State/Form
1 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
Eye Dam. 1 H318  
STOT RE 2 H373 (other:tyroid) (oral) H373
Ox. Liq. 1 H271 H271 GHS03
GHS05
Dgr
Skin Irrit. 2; : 1 % ≤ C < 10 %
Skin Corr. 1B; : 10 % ≤ C < 50 %
Skin Corr. 1A; : C ≥ 50 %
Ox. Liq. 1; : C > 50 %
Eye Irrit. 2; : 1 % ≤ C < 10 %
Ox. Liq. 2; : C ≤ 50 %
Note B
yes State/Form
1 View details
Met. Corr. 1 H290 H290
Skin Corr. 1A H314 H314
Ox. Liq. 1 H271 H271 GHS03
GHS08
GHS07
GHS05
Dgr
State/Form
1 View details
Met. Corr. 1 H290 H290
Acute Tox. 4 H302 H302
Skin Corr. 1A H314 H314
STOT RE 2 H373 (dermal,inhalati...) H373

Number of Aggregated Notifications: 18